ADVANCED MALIGNANT SOLID NEOPLASM
Clinical trials for ADVANCED MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers, but study ends early
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or slo…
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
Genetic testing guides cancer treatment in new study
Disease control TerminatedThis study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal …
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
Immunotherapy duo shows promise for HIV patients with tough cancers
Disease control TerminatedThis study tested a combination of two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who also had advanced solid tumors or Hodgkin lymphoma. The goal was to find the safest dose and see if the drugs could shrink tumors. The trial was stopped early, but it prov…
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
Cancer combo trial halted early: what we learned
Disease control TerminatedThis early-stage trial tested a new immunotherapy drug (BMS-986218) combined with another immunotherapy (nivolumab) and precise radiation for people with advanced solid tumors that had spread. The goal was to see if the combination was safe and could shrink tumors. The study was …
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC